DR-TB Regimen Will Save 190,000+ Additional Lives and $1.29B by 2035
The six-month, all-oral BPaL/M regimens for the treatment of drug-resistant TB (DR-TB) are already changing the trajectory of DR-TB care
Featured News
TB Alliance Welcomes WHO Prequalification of Lupin’s Pretomanid Product
NEW YORK (September 12, 2025)—Lupin Limited, a leading pharmaceutical company headquartered in India, has been granted prequalification by the World
TB Alliance Congratulates Dr. Kathleen Schostack on Her Retirement
As Senior Vice President of Program and Alliance Management, Dr. Schostack played a vital role in advancing TB drug development
TB Experts Rally Around New, Shortened TB Treatments
Regional meeting in Peru convened by PeerLINC, a global peer-to-peer initiative, brings together 20 countries to accelerate collaboration and scale-up
The Biggest Challenge to Ending TB is not Scientific
Statement from TB Alliance on World TB Day For most of human history, tuberculosis (TB) has been the world’s deadliest
Mel Spigelman on the future of TB treatment and the evolution of TB Alliance
2025 marks the 25th anniversary of TB Alliance. Throughout the year, we are sitting down with leaders and visionaries in
Ariel Pablos-Mendez on the past, present, and future of TB research and the TB Alliance
February 8th marks the 25th anniversary of the signing of the Cape Town Declaration, which birthed TB Alliance. Throughout the
Funding for TB and Neglected Disease Research Must Increase to Realize Promise of New Technologies
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW YORK (January 29, 2025)—The G-FINDER 2024 Neglected
TB Alliance Joins Indonesia’s High-Level Meeting on TB
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health.
New Clinical Trial Examines Use of Novel Compound Telacebec in Buruli Ulcer Patients
NEW YORK (August 21, 2024) – In July 2024, a Phase 2 proof-of-concept study was initiated to explore the use